about
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective StudiesSerum uric acid as a prognostic marker in the setting of advanced vascular disease: a prospective study in the elderly.3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.Xanthine oxidase inhibitors in ischaemic heart disease.Management of stable angina: A commentary on the European Society of Cardiology guidelines.Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling PathwayHyperuricaemia in cardiovascular diseases: a passive or an active player?Xanthine oxidase contributes to sustained airway epithelial oxidative stress after scald burn.Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study.Sex-related relationships between uric acid and target organ damage in hypertension.Uric acid and cardiovascular risk: What genes can say.Enhancement of pharmacological effects of uricosuric agents by concomitant treatment with pyrazinamide in rats.Uricaemia and left ventricular mass in hypertensive patients.
P2860
Q36099467-69EC22A1-91EE-41B7-B1EB-DEDEC3D7BE50Q36162192-AEA45AF7-A483-41AE-8AAF-0B8A115BC0DDQ37277498-760C9A50-CD58-4925-8A49-04BD292A8B43Q37386378-4F7DEBB6-3AED-4513-9EA7-DF35085F9458Q38853112-9E9658CF-2D16-49C8-BEA7-E281AEE2D23AQ39324330-C3DFA5F8-E67D-4EF7-B9C2-6A6F5AEC0070Q39738089-F509085A-57BA-4D96-AB95-82B3CCD14D18Q42330303-DC156030-CD85-455E-B2C4-084BCBB7FAB8Q42756654-56B8A35E-D659-4BD4-85DF-07F70F248231Q46265210-80DA624B-F719-4D95-AEAF-23796F4B9ACEQ47326970-E3880A25-A73B-42ED-98EB-D0613AEB2EAAQ47419678-FD478792-C604-49EE-ABE7-285633D4C303Q48102504-F6E35165-4C20-49FE-B166-F3C4D614CEA2Q48172752-27C6724A-A9A1-4D12-8062-66A525CA2F72Q50636707-D1DEF9EA-5876-422E-9843-834EE5C895D9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Beyond gout: uric acid and cardiovascular diseases.
@en
type
label
Beyond gout: uric acid and cardiovascular diseases.
@en
prefLabel
Beyond gout: uric acid and cardiovascular diseases.
@en
P1476
Beyond gout: uric acid and cardiovascular diseases.
@en
P2093
E Agabiti-Rosei
P356
10.1185/03007995.2013.790804
P407
P478
29 Suppl 3
P577
2013-04-24T00:00:00Z